Ironwood Pharmaceuticals | Les Charges D'Exploitation



Operating Expenses Changement Date
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Agios Pharmaceuticals USD 135.77M 1.11B 2024-12
Almirall EUR 195.38M 68.92M 2024-06
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Amarin USD 67.47M 549K 2024-09
Ardelyx USD 108M 12M 2024-12
Astellas Pharma JPY 395.77B 237.82B 2025-03
AstraZeneca USD 12.86B 2.06B 2024-12
Charles River Laboratories USD 1.17B 277.88M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
Incyte USD 877.18M 114.6M 2024-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
Moderna USD 2.21B 280M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Pacira USD 162.55M 145.55M 2024-12
PTC Therapeutics USD 275.66M 24.36M 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Takeda JPY 1.08T 85.39B 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12



Ironwood Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.